# Phase-2A Star Comprehensive Real Review Workload Checkpoint

Date: 2026-08-15
Status: OBSERVED — REVIEW SCALING NOT YET PROVEN

## Purpose

Record the first Phase-2A reviewer-ready workload generated from a real governed Health policy-wording source and routed through MO-029 without synthetic groups or invented reviewer effort.

## Source lineage

- Product: `star_health:star_comprehensive`
- Registered policy wording SHA-256: `b1dbe8fb78646f75566d47c32b7ebfa27c4071941c8f548224c461ee35a8021f`
- Governed source currentness: `current_observed_reviewed`
- Parsed artifact: `processed/pdf_parse/b1dbe8fb78646f75566d47c32b7ebfa27c4071941c8f548224c461ee35a8021f.json`
- Parse result observed locally: 48 pages, 48 pages with text

## Observed extraction and review workload

The real Star Comprehensive policy wording was passed through the existing generic currency/sum-insured extraction primitive and reviewer-record generator.

Observed result:

- extracted currency candidates: 12
- reviewer-ready groups: 12
- grouping compression: 0%

Therefore this sample does not demonstrate workload reduction through grouping.

## MO-029 routing result

The 12 reviewer-ready groups were passed through `ReviewRiskRoutingContract`.

Observed routing:

- critical: 0
- high: 12
- medium: 0
- low: 0
- adjudication: none
- publication: none

All 12 groups therefore require the `senior_review` route under the certified MO-029 policy.

## Interpretation

MO-029 operated as designed: it did not downgrade material ambiguity simply to reduce review cost. The first real workload sample shows that review-risk routing is operational, but it does not yet demonstrate sub-linear review scaling or reduced senior-review demand.

The result must not be represented as a Phase-2A review-scaling success. The correct conclusion is that the current generic currency extraction/review path preserves substantial unresolved semantic or binding ambiguity for this source.

## Governance consequences

1. Star review routing is no longer `not_applicable_no_review_input`; reviewer-ready input now exists and routing is required.
2. The Phase-2A batch audit must bind `knowledge/factory/governance/phase_2a_star_review_risk_routing.json` for Star.
3. Bajaj My Health Care and Activ One remain `not_applicable_no_review_input` until real reviewer-ready inputs are generated for them.
4. No routing result accepts evidence, creates a canonical fact, changes entitlement/currentness, or authorizes publication.
5. No product-specific production reasoning code is justified by this result.

## Next architecture question

The next Phase-2A experiment should identify why these 12 groups are all high risk before changing routing thresholds. Any improvement should come from better generic evidence structure, grouping, or ambiguity resolution upstream. Risk policy must not be weakened merely to improve the metric.

## Non-claims

This checkpoint does not claim:

- that Phase-2A is closed;
- that review throughput is sub-linear;
- that human review time has been measured;
- that Star monetary candidates are accepted product facts;
- that any extracted amount is correctly bound to a product benefit or option;
- that any routed group has been adjudicated or published.
